Evidence map›Paper›PMID 41640555›Full record

ArticleAfrican health sciences2025

Patterns of bacterial pathogens and their antimicrobial susceptibility from blood culture specimens in Wad Medani, Sudan: a four-year laboratory-based, cross-sectional study.

Yousif B Hamadalneel, Hifa O Ahmed, Marwa F Alamin

Abstract read
In one paragraph

Article in African health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yousif B HamadalneelDepartment of Clinical Pharmacy & Pharmacy Practice, Faculty of Pharmacy, University of Gezira, Wad Medani, Sudan.
Hifa O AhmedDepartment of Clinical Pharmacy & Pharmacy Practice, Faculty of Pharmacy, University of Gezira, Wad Medani, Sudan.
Marwa F AlaminDepartment of Molecular Biology, Institute of Endemic Disease, Khartoum University, Khartoum, Sudan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Antibiotic-resistant bacterial bloodstream infections are rapidly emerging, which makes successful treatment challenging. Therefore, this study aimed to determine the patterns of bacterial pathogens and their antimicrobial susceptibility from blood culture samples. Methods: This was a cross-sectional study. All clinical samples were collected from patients at Wad Medani and investigated at the Pathology Center for Diagnosis and Research, Faculty of Medicine, University of Gazira, Sudan, from the 1st of January, 2020, to the 15th of October, 2023. Results: Overall, 577 blood samples were cultured. Among these samples, 86 (14.9%) exhibited bacterial growth. S. aureus (40.7%) and E. coli (40.7%) were the most frequently isolated bacteria. The most sensitive drugs to S. aureus were vancomycin 100% (13/13) and linezolid 86.7% (13/15), whereas the most sensitive drugs to E. coli were norfloxacin 88.9% (8/9), imipenem 85.7% (6/7), and levofloxacin 84% (21/25). The rate of bacterial growth has steadily increased over time, from 5% in 2020 to 24.9% in 2023. Conclusions: This study revealed a modest rate of 14.9% of bloodstream infections, which has steadily increased over the years. The most frequently isolated bacteria were S. aureus and E. coli. Vancomycin was the most susceptible drug to isolated bacteria.

Indexed as

Anti-Bacterial AgentsBacteremiaBacteriaAdolescentAdultBlood CultureChildChild, PreschoolCross-Sectional StudiesDrug Resistance, BacterialEscherichia coliFemaleHumansMaleMicrobial Sensitivity TestsMiddle AgedAnti-Bacterial Agentsantimicrobial susceptibilitybacterial pathogensblood culturepatternsspecimensSudanWad Medani

Identifiers

PMID41640555
PMCPMC12865092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.